Geoffrey Masuyer
Geoffrey Masuyer
Unknown affiliation
Verified email at dbb.su.se
Title
Cited by
Cited by
Year
Identification and characterization of a novel botulinum neurotoxin
S Zhang, G Masuyer, J Zhang, Y Shen, D Lundin, L Henriksson, ...
Nature communications 8 (1), 1-10, 2017
1252017
Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides
G Masuyer, SLU Schwager, ED Sturrock, RE Isaac, KR Acharya
Scientific reports 2, 717, 2012
1102012
Identification of a botulinum neurotoxin-like toxin in a commensal strain of Enterococcus faecium
S Zhang, F Lebreton, MJ Mansfield, SI Miyashita, J Zhang, ...
Cell host & microbe 23 (2), 169-176. e6, 2018
752018
Engineered botulinum neurotoxins as new therapeutics
G Masuyer, JA Chaddock, KA Foster, KR Acharya
Annual review of pharmacology and toxicology 54, 27-51, 2014
562014
NUDT15 hydrolyzes 6-thio-deoxyGTP to mediate the anticancer efficacy of 6-thioguanine
NCK Valerie, A Hagenkort, BDG Page, G Masuyer, D Rehling, M Carter, ...
Cancer research 76 (18), 5501-5511, 2016
552016
Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the α1A‐adrenoceptor
L Quinton, E Girard, A Maiga, M Rekik, P Lluel, G Masuyer, M Larregola, ...
British journal of pharmacology 159 (2), 316-325, 2010
492010
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation
T Visnes, A Cázares-Körner, W Hao, O Wallner, G Masuyer, O Loseva, ...
Science 362 (6416), 834-839, 2018
432018
Structure based drug design of angiotensin-I converting enzyme inhibitors
C S Anthony, G Masuyer, E D Sturrock, K R Acharya
Current medicinal chemistry 19 (6), 845-855, 2012
412012
The structure of the tetanus toxin reveals pH‐mediated domain dynamics
G Masuyer, J Conrad, P Stenmark
EMBO reports 18 (8), 1306-1317, 2017
372017
Botulinum and tetanus neurotoxins
M Dong, G Masuyer, P Stenmark
Annual review of biochemistry 88, 811-837, 2019
362019
Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2‐adrenoceptors
C Rouget, L Quinton, A Maďga, C Gales, G Masuyer, C Malosse, ...
British journal of pharmacology 161 (6), 1361-1374, 2010
362010
Structural characterization of angiotensin I‐converting enzyme in complex with a selenium analogue of captopril
M Akif, G Masuyer, SLU Schwager, BJ Bhuyan, G Mugesh, RE Isaac, ...
The FEBS journal 278 (19), 3644-3650, 2011
352011
Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors
RG Douglas, RK Sharma, G Masuyer, L Lubbe, I Zamora, KR Acharya, ...
Clinical science 126 (4), 305-313, 2014
342014
Glycans confer specificity to the recognition of ganglioside receptors by botulinum neurotoxin A
C Hamark, RPA Berntsson, G Masuyer, LM Henriksson, R Gustafsson, ...
Journal of the American Chemical Society 139 (1), 218-230, 2017
322017
Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence
G Masuyer, CJ Yates, ED Sturrock, KR Acharya
Biological Chemistry 395 (10), 1135-1149, 2014
292014
Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE)
CJ Yates, G Masuyer, SLU Schwager, M Akif, ED Sturrock, KR Acharya
Journal of Biological Chemistry 289 (3), 1798-1814, 2014
232014
Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A
G Masuyer, N Thiyagarajan, PL James, PMH Marks, JA Chaddock, ...
Biochemical and biophysical research communications 381 (1), 50-53, 2009
232009
A neurotoxin that specifically targets Anopheles mosquitoes
E Contreras, G Masuyer, N Qureshi, S Chawla, HS Dhillon, HL Lee, ...
Nature communications 10 (1), 1-10, 2019
202019
Structural characterisation of the catalytic domain of botulinum neurotoxin X-high activity and unique substrate specificity
G Masuyer, S Zhang, S Barkho, Y Shen, L Henriksson, S Košenina, ...
Scientific reports 8 (1), 1-10, 2018
162018
Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin‐I converting enzyme
G Masuyer, M Akif, B Czarny, F Beau, SLU Schwager, ED Sturrock, ...
The FEBS Journal 281 (3), 943-956, 2014
162014
The system can't perform the operation now. Try again later.
Articles 1–20